Stock comparison
LeMaitre Vascular
Medtronic
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
MDT
Medtronic
Market cap
$100.91B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | MDT | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 58D | LMAT |
| Benjamin Graham | 89A | 63C | LMAT |
| Philip Fisher | 81C | 50C | LMAT |
| Peter Lynch | 67B | 55C | LMAT |
| Joel Greenblatt | 56D | 39D | LMAT |
| Charlie Munger | 68D | 51D | LMAT |
| Terry Smith | 69D | 52D | LMAT |
Side-by-side metrics
| Metric | LMAT | MDT |
|---|---|---|
| Market cap | $2.23B | $100.91B |
| P/E (TTM) | 37.1x | 21.2x |
| EV/EBIT | 36.6x | 20.9x |
| ROIC (TTM) | 9.43% | 6.43% |
| Gross margin | 72.39% | 61.95% |
| Net margin | 24.35% | 13.0% |
| Revenue CAGR 5y | 12.75% | 2.73% |
| EPS CAGR 5y | 19.04% | 7.88% |
| Debt / Equity | 0.5x | 0.6x |
| Dividend yield | 0.84% | 3.73% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Revenue CAGR 5y12.75%vs 2.73%+79%
- EPS CAGR 5y19.04%vs 7.88%+59%
- Net margin24.35%vs 13.0%+47%
- ROIC (TTM)9.43%vs 6.43%+32%
MDT leads on
- Market cap$100.91Bvs $2.23B+98%
- Dividend yield3.73%vs 0.84%+78%
- P/E (TTM)21.2xvs 37.1x+43%
- EV/EBIT20.9xvs 36.6x+43%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.